These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 21649582)

  • 1. Serotonin receptors of type 6 (5-HT6): what can we expect from them?
    Marazziti D; Baroni S; Catena Dell'Osso M; Bordi F; Borsini F
    Curr Med Chem; 2011; 18(18):2783-90. PubMed ID: 21649582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin receptors of type 6 (5-HT6): from neuroscience to clinical pharmacology.
    Marazziti D; Baroni S; Borsini F; Picchetti M; Vatteroni E; Falaschi V; Catena-Dell'Osso M
    Curr Med Chem; 2013; 20(3):371-7. PubMed ID: 23157629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-HT6 pharmacology inconsistencies.
    Borsini F; Bordi F; Riccioni T
    Pharmacol Biochem Behav; 2011 Apr; 98(2):169-72. PubMed ID: 21192969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropharmacological profile of novel and selective 5-HT6 receptor agonists: WAY-181187 and WAY-208466.
    Schechter LE; Lin Q; Smith DL; Zhang G; Shan Q; Platt B; Brandt MR; Dawson LA; Cole D; Bernotas R; Robichaud A; Rosenzweig-Lipson S; Beyer CE
    Neuropsychopharmacology; 2008 May; 33(6):1323-35. PubMed ID: 17625499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole spectrum analysis of ligand efficacy at constitutively active human wild-type and S267K 5-HT6 receptors in HEK-293F cells.
    Romero G; Pujol M; Pérez P; Buschmann H; Pauwels PJ
    J Pharmacol Toxicol Methods; 2007; 55(2):144-50. PubMed ID: 16769227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin 5-HT
    Ferrero H; Solas M; Francis PT; Ramirez MJ
    CNS Drugs; 2017 Jan; 31(1):19-32. PubMed ID: 27914038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological Evidence for 5-HT6 Receptor Modulation of 5-HT Neuron Firing in Vivo.
    Brouard JT; Schweimer JV; Houlton R; Burnham KE; Quérée P; Sharp T
    ACS Chem Neurosci; 2015 Jul; 6(7):1241-7. PubMed ID: 25837696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arylpiperazine derivatives acting at 5-HT(1A) receptors.
    López-Rodríguez ML; Ayala D; Benhamú B; Morcillo MJ; Viso A
    Curr Med Chem; 2002 Feb; 9(4):443-69. PubMed ID: 11945120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-HT
    Brodsky M; Lesiak AJ; Croicu A; Cohenca N; Sullivan JM; Neumaier JF
    Brain Res; 2017 Apr; 1660():10-19. PubMed ID: 28087224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-ht6 receptors.
    Woolley ML; Marsden CA; Fone KC
    Curr Drug Targets CNS Neurol Disord; 2004 Feb; 3(1):59-79. PubMed ID: 14965245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective 5-HT6 receptor ligands: progress in the development of a novel pharmacological approach to the treatment of obesity and related metabolic disorders.
    Heal DJ; Smith SL; Fisas A; Codony X; Buschmann H
    Pharmacol Ther; 2008 Feb; 117(2):207-31. PubMed ID: 18068807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin and human myoclonus. Rationale for the use of serotonin receptor agonists and antagonists.
    Pranzatelli MR
    Arch Neurol; 1994 Jun; 51(6):605-17. PubMed ID: 7515228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting 5-HT receptors for the treatment of obesity.
    Sargent BJ; Henderson AJ
    Curr Opin Pharmacol; 2011 Feb; 11(1):52-8. PubMed ID: 21330209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A microdialysis study of ST1936, a novel 5-HT6 receptor agonist.
    Valentini V; Frau R; Bordi F; Borsini F; Di Chiara G
    Neuropharmacology; 2011 Mar; 60(4):602-8. PubMed ID: 21185318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 5-HT1A receptor and its ligands: structure and function.
    Olivier B; Soudijn W; van Wijngaarden I
    Prog Drug Res; 1999; 52():103-65. PubMed ID: 10396127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of central 5-HT receptors and their function.
    Barnes NM; Sharp T
    Neuropharmacology; 1999 Aug; 38(8):1083-152. PubMed ID: 10462127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacophore models for metabotropic 5-HT receptor ligands.
    Bojarski AJ
    Curr Top Med Chem; 2006; 6(18):2005-26. PubMed ID: 17017971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-HT6 receptor ligands, EMD386088 and SB258585, differentially regulate 5-HT6 receptor-independent events.
    Yun HM; Rhim H
    Toxicol In Vitro; 2011 Dec; 25(8):2035-40. PubMed ID: 21864673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress in Investigational Agents Targeting Serotonin-6 Receptors for the Treatment of Brain Disorders.
    Nirogi R; Jayarajan P; Shinde A; Mohammed AR; Grandhi VR; Benade V; Goyal VK; Abraham R; Jasti V; Cummings J
    Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of serotonin receptors in the action of atypical antipsychotic drugs.
    Meltzer HY; Massey BW
    Curr Opin Pharmacol; 2011 Feb; 11(1):59-67. PubMed ID: 21420906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.